We performed quantitative real-time RT-PCR assays with the LightCycler RNA amplification kit hybridization probes (Roche Diagnostics, Alameda, CA). The final 

Norgen's COVID-19 TaqMan RT-PCR Kit (E/RdRP genes) is a multiplexed assay designed for simple, reliable and rapid qualitative detection of SARS-CoV-2 

Detect RNA from multiple respiratory viruses simultaneously with the TaqMan SARS-CoV-2, FluA/B, RSV RT-PCR Assay Kit, a highly accurate, real-time PCR multiplex assay that allows

Norgen's 2019-nCoV TaqMan RT-PCR Kit provides SARS-CoV-2 detection based on the assays and protocols developed by the CDC. The Primer & Probe Mixes contain all 3 CDC developed assays in individual tubes. All assays are premixed to the working concentrations recommended by the CDC.

Kit Components The TaqMan One-Step RT-PCR Master Mix Reagents Kit contains sufficient reagent to perform 200 50-µL reactions. The mix is optimized for TaqMan One-Step RT-PCR and contains AmpliTaq Gold enzyme, dNTPs with dUTP, Passive Reference, and optimized buffer components. An additional vial, MultiScribe and RNase Inhibitor Mix, is

Pre-designed TaqMan® Gene Expression Assay kits (Life Technologies) used for quantitative real-time RT-PCR. Gene symbol. Transporter/Receptor.

Applied Biosystems TaqMan MicroRNA Assays quantitate miRNAs with the specificity and sensitivity of TaqMan Assay chemistry. A simple, two-step protocol 

2022/9/12 · The TaqMan SARS-CoV-2, Flu A/B, and RSV Multiplex Assay were assessed by using two different types of specimens – nasopharyngeal and saliva samples. The nasopharyngeal swab was collected in a disposable virus sampling tube containing 3 mL of virus transport medium.

and Preamplification Pools Using TaqMan® MicroRNA Assays (Pub. No. 4465407). IMPORTANT! TaqMan ® MicroRNA Assays and TaqMan Small RNA Assays are optimized for the MuLV Reverse Transcriptase contained in the TaqMan® MicroRNA Reverse Transcription Kit. Assay performance with other reverse transcriptase enzymes cannot be guaranteed. Before you

The assay allows customers to easily evaluate TaqMan MicroRNA. Assay technology without having to invest in the full human panel kit. Identified as a candidate 

The kit includes three assays that target SARS-CoV-2 genes, and one positive control assay that targets the Human RNase P RPPH1 gene: • Assays target three different viral genomic